<SEC-DOCUMENT>0001062822-23-000028.txt : 20230628
<SEC-HEADER>0001062822-23-000028.hdr.sgml : 20230628
<ACCEPTANCE-DATETIME>20230628162059
ACCESSION NUMBER:		0001062822-23-000028
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230623
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230628
DATE AS OF CHANGE:		20230628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXICON PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001062822
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				760474169
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30111
		FILM NUMBER:		231052323

	BUSINESS ADDRESS:	
		STREET 1:		2445 TECHNOLOGY FOREST BLVD.
		STREET 2:		SUITE 1100
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381
		BUSINESS PHONE:		2818633000

	MAIL ADDRESS:	
		STREET 1:		2445 TECHNOLOGY FOREST BLVD.
		STREET 2:		SUITE 1100
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON PHARMACEUTICALS, INC./DE
		DATE OF NAME CHANGE:	20070426

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON GENETICS INC/TX
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrx-20230623.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:a9a584a3-71bb-4a0e-82b1-0e606e5ca83e,g:48d8699d-3723-4c16-b1d0-e78fe52d0098,d:845c3fd1e3a9405d9fa87d262cbff90b--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lxrx-20230623</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityCentralIndexKey" id="f-21">0001062822</ix:nonNumeric><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lxrx-20230623.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if0e98ee507db4c35829888646775370c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001062822</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i845c3fd1e3a9405d9fa87d262cbff90b_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">June 23, 2023</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityRegistrantName" id="f-3">Lexicon Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:32.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityFileNumber" id="f-5">000-30111</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityTaxIdentificationNumber" id="f-6">76-0474169</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityAddressAddressLine1" id="f-7">2445 Technology Forest Blvd., 11th Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityAddressCityOrTown" id="f-8">The Woodlands</ix:nonNumeric>, <ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Texas</ix:nonNumeric> <ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityAddressPostalZipCode" id="f-10">77381</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices and Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:CityAreaCode" id="f-11">281</ix:nonNumeric>) <ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:LocalPhoneNumber" id="f-12">863-3000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:34.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:Security12bTitle" id="f-13">Common Stock, par value $0.001</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:TradingSymbol" id="f-14">LXRX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-15">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-19">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i845c3fd1e3a9405d9fa87d262cbff90b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.01 &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Entry into a Material Definitive Agreement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">On June 23, 2023, Lexicon and one of its subsidiaries entered into a third amendment (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Third Amendment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) to its loan and security agreement (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) with Oxford Finance LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Oxford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) bifurcating the third tranche under which $75 million was previously available for draw at Lexicon&#8217;s option prior to June 30, 2023.  Under the terms of the Third Amendment, $50 million remains available for draw at Lexicon&#8217;s option prior to June 30, 2023 under the third tranche and $25 million will be available for draw at Lexicon&#8217;s option between December 1 and December 31, 2023 under a new fourth tranche.  The previous fourth tranche, under which $25 million is available for draw at Lexicon&#8217;s option, subject to Oxford&#8217;s consent, at any time prior to the expiration of the interest-only payment period, is now a fifth tranche.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Subject to and upon funding of the fourth tranche, Lexicon will grant Oxford a warrant to purchase shares of its common stock having a value equal to 1.75% of such tranche, as determined by reference to a 10-day average closing price of the shares. The warrant will have an exercise price equal to such average closing price, be exercisable for a five-year period from the date of issuance and feature a net cashless exercise provision.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The index rate applicable to each tranche under the Loan Agreement will transition from the 30-day U.S. Dollar LIBOR to the 1-month CME Term SOFR and the spread above such index rate is reduced from 7.90% to 7.00% for the third and fourth tranches.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The existing financial covenant relating to minimum cash balance requirements will only be applicable if Lexicon draws the fourth tranche and following its funding.  The existing unused fee will only be due in the event Lexicon does not draw the full amount available under the fourth tranche.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing summary does not purport to be complete and is qualified in its entirety by the Third Amendment, a copy of which is attached to this report as Exhibit 10.1 and incorporated herein by reference.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i845c3fd1e3a9405d9fa87d262cbff90b_110"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 2.03 &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On June 28, 2023, Lexicon exercised its option to draw the third $50 million tranche under the Loan Agreement and the third tranche was funded on such date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Pursuant to the terms of the Loan Agreement, concurrent with the funding of the third tranche, Lexicon granted Oxford a warrant to purchase 183,824 shares of its common stock at an exercise price of $2.38 per share, exercisable for a five-year period from the date of issuance.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i845c3fd1e3a9405d9fa87d262cbff90b_116"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 3.02 &#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information contained in Item 2.03 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.02. The warrants discussed above and the underlying shares of common stock have not been registered under the Securities Act of 1933, as amended (the &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and they have been issued in reliance upon the exemption from the registration requirements of the Securities Act provided by Section 4(2) thereof.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i845c3fd1e3a9405d9fa87d262cbff90b_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9.01 &#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:13.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.061%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#8224;10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm">Third A</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm">mendment to Loan and Security Agreement, date</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm">d</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm">June </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm">23</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="exh101thirdamendmenttooxfo.htm">, 2023, with Oxford Finance, LLC</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX-104</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by &#8220;[**]&#8221;) has been excluded from this exhibit because it is both not material and would likely cause competitive harm to the Company if publicly disclosed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i845c3fd1e3a9405d9fa87d262cbff90b_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:52.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lexicon Pharmaceuticals, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:   June 28, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/ Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">President and General Counsel</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh101thirdamendmenttooxfo.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1e7e5d8e200e4a3bb583ca1299890f0f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#91;**&#93; Certain information has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT</font></div><div style="padding-right:-18pt;text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Third Amendment to Loan and Security Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) is entered into as of June 23, 2023, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 115 South Union Street, Suite 300, Alexandria, VA  22314 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Oxford</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), as collateral agent (in such capacity, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), the Lenders listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereof or otherwise a party hereto from time to time including OXFORD FINANCE CREDIT FUND II, LP, by its manager Oxford Finance Advisors, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Credit Fund II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), OXFORD FINANCE CREDIT FUND III, LP, by its manager Oxford Finance Advisors, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Credit Fund III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), OXFORD FINANCE FUNDING IX, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Funding IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), OXFORD FINANCE FUNDING XIII, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Funding XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), and OXFORD FINANCE FUNDING 2023-1, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Funding 2023-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;&#59; together with Credit Fund II, Credit Fund III, Funding IX, and Funding XIII, each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), LEXICON PHARMACEUTICALS, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) and LEXICON PHARMACEUTICALS (NEW JERSEY), INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Lex-NJ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), each a Delaware corporation with offices located at 2445 Technology Forest Blvd., 11th Floor, The Woodlands, TX  77381 (Parent and Lex-NJ, individually and collectively, jointly and severally, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, Collateral Agent, Borrower and the Lenders listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to the Loan Agreement (as defined below) or otherwise a party thereto from time to time including Oxford in its capacity as a Lender have entered into that certain Loan and Security Agreement, dated as of March 17, 2022 (as amended, supplemented or otherwise modified from time to time, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) pursuant to which Lenders have provided to Borrower certain loans in accordance with the terms and conditions thereof&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, Borrower, Lenders and Collateral Agent desire to amend certain provisions of the Loan Agreement as provided herein and subject to the terms and conditions set forth herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NOW, THEREFORE, in consideration of the promises, covenants and agreements contained herein, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Borrower, Lenders and Collateral Agent hereby agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Loan Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Section 13.1 of the Loan Agreement hereby is amended to insert the following defined term in appropriate alphabetical order&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">1-Month CME Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is the 1-month CME Term SOFR reference rate as published by the CME Term SOFR Administrator on the CME Term SOFR Administrator&#8217;s Website.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is, initially, the 1-Month CME Term SOFR&#59; provided, that if a Benchmark Transition Event has occurred with respect to the 1-Month CME Term SOFR or the then-current Benchmark, then &#8220;Benchmark&#8221; means the applicable replacement rate that has replaced the immediately preceding benchmark rate pursuant to the defined term &#8220;Basic Rate&#8221;.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means the occurrence of one or more of the following events with respect to the then-current Benchmark&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)  a public statement or publication of information by or on behalf of the administrator for such Benchmark announcing that such Person has ceased or will cease to provide such Benchmark, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide such Benchmark&#59; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)  a public statement or publication of information by the regulatory supervisor for the administrator for such Benchmark, the U.S. Federal Reserve System, an insolvency official with jurisdiction over the administrator for such Benchmark, a resolution authority with jurisdiction over the administrator for such Benchmark or a court or an entity </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">with similar insolvency or resolution authority over the administrator for such Benchmark, which states that the administrator for such Benchmark has ceased or will cease to provide such Benchmark permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide such Benchmark&#59; or</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)   a public statement or publication of information by the regulatory supervisor for the administrator for such Benchmark announcing that such Benchmark is no longer representative or in compliance with the International Organization of Securities Commissions Principles for Financial Benchmarks. </font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CME Term SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is CME Group Benchmark Administration Limited, as administrator of the forward-looking term SOFR, or any successor administrator.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CME Term SOFR Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the website of the CME Group Benchmark Administrator at </font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">http&#58;&#47;&#47;www.cmegroup.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, or any successor source.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fourth Draw Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is, so long as Borrower has received Sotagliflozin FDA Approval, the period commencing on December 1, 2023 and ending on the earliest of (i) December 31, 2023&#59; and (ii) the occurrence of an Event of Default&#59; provided, however, that the Fourth Draw Period shall not commence if on December 1, 2023 an Event of Default has occurred and is continuing.  As of the Third Amendment Effective Date, Lenders acknowledge Borrower&#8217;s receipt of Sotagliflozin FDA Approval. </font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term E Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2.2(a)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereof. </font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Third Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means June 23, 2023.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">The following defined terms in Section 13.1 of the Loan Agreement hereby are amended and restated in their entireties to read as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basic Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is with respect to each Term Loan, the per annum rate of interest (based on a year of three hundred sixty (360) days) equal to the greater of (a) eight and one-hundredth percent (8.01%) and (b) the sum of (i) the 1-Month CME Term SOFR on the last Business Day of the month that immediately precedes the month in which the interest will accrue, (ii) 0.10% and (iii) (I) for any Term A Loan or Term B Loan, seven and ninety one-hundredths percent (7.90%) and (II) for any Term C Loan or Term D Loan, seven percent (7.00%).  Notwithstanding the foregoing, (i) in no event shall the Basic Rate for any Term Loan be less than eight and one-hundredth percent (8.01%), and (ii) upon the occurrence of a Benchmark Transition Event, Collateral Agent may, in good faith and with reference to the margin above such interest rate in this definition, amend this Agreement to replace the Benchmark with a replacement interest rate and replacement margin above such interest rate that results in a substantially similar interest rate floor and total rate in effect immediately prior to the effectiveness of such replacement interest rate and replacement margin, and any such amendment shall become effective at 5&#58;00 p.m. Eastern time on the third Business Day after Collateral Agent has notified Borrower of such amendment.  Any determination, decision or election that may be made by Collateral Agent pursuant hereto will be conclusive and binding absent manifest error and may be made in Collateral Agent&#8217;s sole discretion and without consent from any other party.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">The following defined terms hereby are deleted from Section 13.1 and wherever else they may appear in the Loan Agreement&#58; &#8220;LIBOR Replacement Rate&#8221;, &#8220;LIBOR Replacement Spread&#8221;, and &#8220;LIBOR Transition Event&#8221;. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Section 2.2(a)(iii) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(iii)        Subject to the terms and conditions of this Agreement, the Lenders agree, severally and not jointly, during the Third Draw Period, to make term loans to Borrower in an aggregate amount up to Fifty Million Dollars ($50,000,000.00) according to each Lender&#8217;s Term C Loan Commitment as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereto (such term loans are hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term C Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;, and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term C Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  After repayment, no Term C Loan may be re&#8209;borrowed.&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Section 2.2(a)(iv) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(iv)       Subject to the terms and conditions of this Agreement, the Lenders agree, severally and not jointly, during the Fourth Draw Period, to make term loans to Borrower in an aggregate amount up to Twenty-Five </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Million Dollars ($25,000,000.00) according to each Lender&#8217;s Term D Loan Commitment as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereto (such term loans are hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term D Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;, and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term D Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  After repayment, no Term D Loan may be re&#8209;borrowed.&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">New Section 2.2(a)(v) hereby is added to the Loan Agreement as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(v)         Subject to the terms and conditions of this Agreement, upon Borrower&#8217;s written request therefor prior to the Amortization Date, the Lenders may agree, in their sole discretion, severally and not jointly, to make term loans to Borrower in an aggregate amount up to Twenty-Five Million Dollars ($25,000,000.00) according to each Lender&#8217;s Term E Loan Commitment as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> hereto (such term loans are hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term E Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;, and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term E Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;&#59; each Term A Loan, Term B Loan, Term C Loan, Term D Loan or Term E Loan is hereinafter referred to singly as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Term A Loans, Term B Loans, Term C Loans, Term D Loans and the Term E Loans are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">hereinafter referred to collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  After repayment, no Term E Loan may be re&#8209;borrowed.&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Section 2.5(f) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(f)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Unused Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. A fee, payable in full on &#91;**&#93; to Lenders, in an amount equal to &#91;**&#93;, if the Fourth Draw Period expires and Borrower has not drawn the full amount of the Term D Loan (such fee, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Unused Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).&#8221; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Section 3.2(d) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(d)         to the extent not delivered at the Effective Date, duly executed original Secured Promissory Notes and Warrants, in number, form and content acceptable to each Lender, and in favor of each Lender according to its Commitment Percentage, with respect to each Credit Extension made by such Lender after the Effective Date&#59; provided that, Warrants issued after the Effective Date, if at all, shall be on substantially the same form as the Warrants issued to the Lenders as of the Effective Date, and shall be issuable for Shares of Borrower&#8217;s common stock equal to (x) one and seventy-five hundredths percent (1.75%) of the funded amount of any Term B Loan, (y) eight hundred seventy-five thousandths percent (0.875%) of the funded amount of any Term C Loan, and (z) one and seventy-five hundredths percent (1.75%) of the funded amount of any Term D Loan, in each case, divided by the Warrant Price (as defined therein)&#59; and&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">Section 6.10(b) of the Loan Agreement hereby is amended and restated in its entirety to read as follows&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(b)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Minimum Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.   From and after the Funding Date of the Term D Loan, until Borrower achieves trailing &#91;**&#93; sotagliflozin NPR of at least &#91;**&#93; (such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Minimum Cash Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), Borrower shall maintain minimum unrestricted cash, cash equivalents and short-term investments of at least &#91;**&#93; in Collateral Accounts subject to Control Agreements in favor of Collateral Agent, measured as of the last day of each fiscal quarter beginning with the fiscal quarter ending on the First Minimum Cash Test Date and continuing as of the last day of each fiscal quarter during the Minimum Cash Period.&#8221; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to the Loan Agreement hereby is replaced in its entirety with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> attached hereto. </font></div><div><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Limitation of Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;The amendments set forth above are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right, remedy or obligation which Lenders or Borrower may now have or may have in the future under or in connection with any Loan Document, as amended hereby.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, are hereby ratified and confirmed and shall remain in full force and effect.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">To induce Collateral Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Collateral Agent and Lenders as follows&#58; </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:29.07pt">Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Borrower has the power and due authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment&#59; </font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:29.07pt">The organizational documents of Borrower delivered to Collateral Agent on the Effective Date, and updated pursuant to subsequent deliveries by or on behalf of the Borrower to the Collateral Agent, remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect&#59; </font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not contravene (i) any material law or regulation binding on or affecting Borrower, (ii) any material contractual restriction with a Person binding on Borrower, (iii) any material order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (iv) the organizational documents of Borrower&#59; </font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:29.07pt">The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made and filings required to perfect the security interest of the Collateral Agent in the Collateral&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:30.17pt">This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors&#8217; rights.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">Except as expressly set forth herein, the Loan Agreement shall continue in full force and effect without alteration or amendment.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">As a condition to the effectiveness of this Amendment, Collateral Agent shall have received, in form and substance satisfactory to Collateral Agent, the following&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;this Amendment, duly executed by Borrower&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;resolutions, duly adopted by Borrower&#8217;s board of directors authorizing the entry in to and performance of this Amendment&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;an amendment fee equal to &#91;**&#93;, which may be debited (or ACH&#8217;d) from the Designated Deposit Account in accordance with the Loan Agreement&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;all reasonable Lenders&#8217; Expenses incurred through the date of this Amendment, which may be debited (or ACH&#8217;d) from the Designated Deposit Account in accordance with the Loan Agreement&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;such other documents, and completion of such other matters, as Collateral Agent may reasonably deem necessary or appropriate.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, and all of which, taken together, shall constitute one and the same instrument.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">Section 11 of the Loan Agreement (Choice of Law, Venue and Jury Trial Waiver) is incorporated herein by this reference as though set forth in full.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Balance of Page Intentionally Left Blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#93;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the parties hereto have caused this Third Amendment to the Loan Agreement to be executed as of the date first set forth above.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.233%"><tr><td style="width:1.0%"></td><td style="width:42.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.865%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">BORROWER&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LEXICON PHARMACEUTICALS, INC.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LEXICON PHARMACEUTICALS, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ___________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Jeffrey L. Wade</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LEXICON PHARMACEUTICALS (NEW JERSEY), INC.<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; __________________________________________<br>Name&#58; Jeffrey L. Wade<br>Title&#58; President and Chief Financial Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LEXICON PHARMACEUTICALS (NEW JERSEY), INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Jeffrey L. Wade</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; President and Chief Financial Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COLLATERAL AGENT </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OXFORD FINANCE LLC</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ___________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Senior Vice President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Signatures continued, next page</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the parties hereto have caused this Third Amendment to the Loan Agreement to be executed as of the date first set forth above.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.233%"><tr><td style="width:1.0%"></td><td style="width:42.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.865%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">LENDERS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE FUNDING I, LLC</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OXFORD FINANCE FUNDING I, LLC </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Secretary</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE FUNDING IX, LLC<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; __________________________________________<br>Name&#58; Colette H. Featherly<br>Title&#58; Secretary</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE FUNDING IX, LLC</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Secretary</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OXFORD FINANCE FUNDING 2023-1 LLC </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Secretary</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND II LP<br>By&#58; Oxford Finance, Advisors, LLC<br>Its&#58; Manager<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; __________________________________________<br>Name&#58; Colette H. Featherly<br>Title&#58; Senior Vice President</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE FUNDING XIII, LLC</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Senior Vice President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND II LP </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; Oxford Finance, Advisors, LLC</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Its&#58; Manager</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Senior Vice President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OXFORD FINANCE CREDIT FUND III LP </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; Oxford Finance, Advisors, LLC</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Its&#58; Manager</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  __________________________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; Colette H. Featherly</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58; Senior Vice President</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SCHEDULE 1.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Lenders and Commitments</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image.jpg" src="image.jpg" style="height:666px;margin-bottom:5pt;vertical-align:text-bottom;width:654px"></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrx-20230623.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:a9a584a3-71bb-4a0e-82b1-0e606e5ca83e,g:48d8699d-3723-4c16-b1d0-e78fe52d0098-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lxrx="http://lexpharma.com/20230623" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://lexpharma.com/20230623">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20230623_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20230623_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://lexpharma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lxrx-20230623_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:a9a584a3-71bb-4a0e-82b1-0e606e5ca83e,g:48d8699d-3723-4c16-b1d0-e78fe52d0098-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_a8d31ff9-d891-4a42-a3bc-feadec4bac8c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1181bcf3-2eb9-437f-a3db-d0938c70d324_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9e9bfded-a46c-494b-8bb3-61b923652835_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cad3a504-0636-4077-ba42-ba7654039e4a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_407a1066-0ec3-407d-83dc-1a624c4ffc57_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_426a2848-0023-4df7-b08d-90e804224f64_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_1d24d815-de23-493f-9a0d-a706655fbe87_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4de2d722-9636-4b80-bcbc-c12ca139a325_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a3ae7764-c551-4c7b-8207-eb21cd284f56_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bf232a21-3e06-4fef-b35b-66103d9a024c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5b753c99-db4e-45f3-89a8-bbf0443a81de_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_7bb20b62-bdef-4909-aaa9-40de19572a13_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a153fdc5-558c-423e-a506-eaf7d2a0fd8b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_330d128c-ca32-49e6-a12d-ba958631f2ef_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3f948b2f-26af-49f7-956e-46e16f5accb8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1290a327-038d-4c3e-be4e-029d499a4fd4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a08675a3-3cd0-435b-8519-08665320ef93_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f022cccd-60e8-4963-aeeb-c8117205efba_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7e9559bb-af58-43cf-a712-438906f982ea_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7e094f1c-f8a5-4c83-a8cc-bc5e45bffb3b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3edec022-0e7a-4fe5-b5da-22789416b654_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_a2f7927e-8120-4c2f-95f0-18f799b4dbb8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>lxrx-20230623_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:a9a584a3-71bb-4a0e-82b1-0e606e5ca83e,g:48d8699d-3723-4c16-b1d0-e78fe52d0098-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20230623.xsd#Cover"/>
  <link:presentationLink xlink:role="http://lexpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6abcfec6-4f0c-4722-a5bc-27a1c5fa60b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_DocumentType_6abcfec6-4f0c-4722-a5bc-27a1c5fa60b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ca64a549-1e3d-489c-8706-f42a57158172" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityTaxIdentificationNumber_ca64a549-1e3d-489c-8706-f42a57158172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ee125938-6ec4-4dd4-b6d8-21f399dd5deb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityRegistrantName_ee125938-6ec4-4dd4-b6d8-21f399dd5deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f6444a8-6fc3-4236-b6d7-f0896f3c6500" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityFileNumber_2f6444a8-6fc3-4236-b6d7-f0896f3c6500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9fad38df-eda7-459c-90a0-81c20c240e22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9fad38df-eda7-459c-90a0-81c20c240e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_14637ee9-11cf-4626-a73b-896cc1b0f289" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityAddressAddressLine1_14637ee9-11cf-4626-a73b-896cc1b0f289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ea7635c6-e5bd-4bc2-8d48-8430c2c3027a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityAddressCityOrTown_ea7635c6-e5bd-4bc2-8d48-8430c2c3027a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e86099fc-df07-48b5-9611-7af8ac501de0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityAddressStateOrProvince_e86099fc-df07-48b5-9611-7af8ac501de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bb8aae10-d1ee-4647-beb4-3039fba8ae02" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityAddressPostalZipCode_bb8aae10-d1ee-4647-beb4-3039fba8ae02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b3f8aad8-357e-434e-81e6-b26bd418ee8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_CityAreaCode_b3f8aad8-357e-434e-81e6-b26bd418ee8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5f6ba15b-8f03-4d04-b29d-67abf5196585" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_LocalPhoneNumber_5f6ba15b-8f03-4d04-b29d-67abf5196585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4d43161f-a79f-4bad-83bc-2ec34191cf2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_Security12bTitle_4d43161f-a79f-4bad-83bc-2ec34191cf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_44323737-261e-4bbf-a5df-465be79ab996" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_TradingSymbol_44323737-261e-4bbf-a5df-465be79ab996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_943a389d-589a-4d39-a6d0-c56aa4a21061" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_SecurityExchangeName_943a389d-589a-4d39-a6d0-c56aa4a21061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_39b520e3-ae62-42ed-9714-ba34dda5b88f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_WrittenCommunications_39b520e3-ae62-42ed-9714-ba34dda5b88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a67d0d6a-707f-47d6-8c18-5d075ada345f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_SolicitingMaterial_a67d0d6a-707f-47d6-8c18-5d075ada345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_020782c9-7b61-486d-ba02-b64fd2ea0e95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_DocumentPeriodEndDate_020782c9-7b61-486d-ba02-b64fd2ea0e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6fa13cdd-7766-4c54-9096-36b128ba2e63" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_AmendmentFlag_6fa13cdd-7766-4c54-9096-36b128ba2e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2bc3a8d7-c684-4002-9cdd-2360e07f07e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityCentralIndexKey_2bc3a8d7-c684-4002-9cdd-2360e07f07e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_887cc852-ae64-45f4-9c07-7034bd8115f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_PreCommencementTenderOffer_887cc852-ae64-45f4-9c07-7034bd8115f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_8301d4f3-a6ac-4248-a89b-af97aabc10ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_8301d4f3-a6ac-4248-a89b-af97aabc10ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9a4bf5f2-d0b0-46bf-8d8a-f4b5ff4caa99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30001f6e-2afa-4fa6-b470-77391c725931" xlink:to="loc_dei_EntityEmergingGrowthCompany_9a4bf5f2-d0b0-46bf-8d8a-f4b5ff4caa99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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M?7\N'7I\B]*S*+P>O[E]4A1%<^GT/*\0/@B"PGJFTZD(@J 0GHAHVSA"O,-
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M.YU.U?^WP2;3P9;,#TC>,5U>7@)XN1/M=KO(LJS0NAA%T=RR]_?W (#=W5T
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MGN>5+J-?!*M4A5MGO<N&6S9]1*_U^/AHO6[E>5YY_91E=3:;83:;%1I-RF;
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MD[.WQ'%<"-]NMPOAS/"2&4Z?(:8L#OU"V&@TEEJ/KFR9, SGMOV?__RG=3\
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MYI;)\[SR\765G9T=-6>[;:[P,IU.!Y[GX?[^?JWU$A$1$9E8R=P2P^$0CN/
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M+C]UDN4IRS+UW7OE8_UO,V[Y'=5CD^6'+9E;I-/IH-/I6'_K]7IJP/1NMPL
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MTM^=CNV=EL4AY>ZZ+@# =5T.:?Z#E(/KNM8/-EUF]"D84N:Z/.MRD&5907^
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M-C(/#P]+>]Y&HQ&.CX\+YX(@P& PP& PJ)Q?",S/%6RWV_C[[[_GPOWZ]0L
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MPF@TPF P4,/D\O&YL[.#9K/)7OPMAD;F!T.&%H'Y88F[NSL +_-55D6?\P8
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M>_);'P[7AQST\S::S>;<=3U.&3K<MJ]R\C;(L)L^7&M.O6@T&@B"0*=#]*D
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MF]2?3S5</AJ-U-Z@.H>'ATC3M#!<U>_WX7D>@B! I]/!;#:KC%L?4OWUZQ<
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MY:F7]!>TQ;6WMP< ^//G#P#D<<I3//F_+7V#P: 05M].V?:D#V.2)#@\/ 0
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MM/E8R23:,M?7U_G32>#O2QKC\3BOD#P]/6$X'.85(_TIV\/#PU2%L<KQ\3&
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MD&8WO;E67R9/<MKM=IY7]+^#("B$7X79M43/DWH3M^1E/?RL[B)9EF$\'@,
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MIKF5IOO)9%*8@M=Q' R'0PP&@[P;RV0R*:RKOT3XU7^PL9+YR9R=G6%_?Q\
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8J';_#TH2K'P TP94     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139773895719200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0474169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lexicon Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2445 Technology Forest Blvd., 11th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">The Woodlands<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">863-3000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LXRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001062822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>lxrx-20230623_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrx-20230623.xsd" xlink:type="simple"/>
    <context id="if0e98ee507db4c35829888646775370c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001062822</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-21">0001062822</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-2">2023-06-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-3">Lexicon Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-5">000-30111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-6">76-0474169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-7">2445 Technology Forest Blvd., 11th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-8">The Woodlands</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-9">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-10">77381</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-11">281</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-12">863-3000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-13">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-14">LXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-15">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="if0e98ee507db4c35829888646775370c_D20220701-20220930"
      id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MG8+<5E;[[#;O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ G8+<5IE<G",0!@  G"<  !,
M ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "=@MQ6+Y)>
M?H($   D$0  &               @($."   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ G8+<5I^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  &A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lxrx-20230623.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lexpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0540-DocumentPeriodEndDate-Value] In submission type 8-K, DocumentPeriodEndDate value 2023-06-23, is not equivalent to header element periodOfReport value, 06-28-2023, in the Required Context. lxrx-20230623.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="lxrx-20230623.htm">lxrx-20230623.htm</File>
    <File>exh101thirdamendmenttooxfo.htm</File>
    <File>lxrx-20230623.xsd</File>
    <File>lxrx-20230623_lab.xml</File>
    <File>lxrx-20230623_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lxrx-20230623.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "lxrx-20230623.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lxrx-20230623_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrx-20230623_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lxrx-20230623.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lxrx",
   "nsuri": "http://lexpharma.com/20230623",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20230623.htm",
      "contextRef": "if0e98ee507db4c35829888646775370c_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://lexpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20230623.htm",
      "contextRef": "if0e98ee507db4c35829888646775370c_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001062822-23-000028-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062822-23-000028-xbrl.zip
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MAQE*)";91"_N$;W @ 3"#4/'I6@Q3Y@G!G YIB?\<+*].+Z1KA+@4&XTIE+
MN391.(S5<8TN-N)7HAJ'34<@=UV=@KDAKNTP3TEIBMM^Y#%(]\8^!6Z;M N.
MX6;A.2S)HLBG>Y NRIL9AYX<R#R;4]J%8ZGQ5D&6#5*815F<9%RE(28C"5@P
MG$BXC>(0-!V &'[.>=:@UX?M)$@?W 56\2C80JH8P0TT,4ZT=@1]B7R4*+(+
M!\J)@=\>0*@]>>%HP.KDD$>@S8I,X.I$QD3@Q!DY$@A#"4$7&&F!2 !>RK&(
MX)>*)9.L_Q48Q,B1A>A*1,I !@!&U8TKZ>R?%%^]TTNP"Q%IQZ=G'30"$5()
M@%4;H1KZ .LQ"*<$1="5"("U%%BY00BF.@)$78X/Y9237&-#,$+IXQ7W,][W
M1?4M2I3%PA4R4D8I]\1_,^Y.\?V*@=$ZQ@=C]LO]%H037WA#E*0K4IJY%Q>,
MU#. "\)) DS[^O#'$,#ZL=VHK='\,*EP7PS2@^;KVAZ"H<TCF0* _T9A3,R:
M)05'][.42A4*Y6BL@&0$[H<2YHITDDCI1386/(#7)&P(GP(M",9(V/-2Y!;.
M_WG8O&D=XL\172!?&KNUQA(1KSE6YE83(E,&L(B4+E<<C#:=H0JD(-+<$<BK
M*)8@ !CWHQ'OBU2Z( I GXOXKBS_$+AO[J\-]Q98B(V=CW#-B+4_=M@%X&BM
M+L8Z 7%^>GQF@8&,/(4<U-@95_#"<'T@3 ? >6CVQL1 B2K[2D;H?9&3-7-#
MRQO+ #Q<N!P]F>"V2W 5C?W#A%V*?B)3,2^&-QSWO3$QP-]HS.-O=E ;&I9@
M?:N0H:*\C_.4IQPH8]8[RNN6 W#,\^VPBQ@61(8\ZUR1ED!?VP5'')UU\M.T
M,6!\@(6O0I>;'(21"';H9GA4_A9:8V!\Z_QKLQ\T,10#@:+Q0;&@01N+R.>N
MTES$-[1Z7)W^146$Y'@L/%1,_A1V"A8O!27Z^?[HUK+[BC=5])M9%4^DR\[@
M<KVL#1?]G%RT5H4URVXVB)."_33?HZK"DJ= (%N/PU@8B[(P$<45.:F+!,1B
M&;#82GS:;L 6WV88+*4J;G@Y" ^25P U]5WN\Y?+S$'G*[7>%^!U#0QL>47K
MP^6JKK$0U3P(PBQP$?HD"^GG3^"@Z])U5_!$!3\G$IPY^H@XT0I@YG$.BT#Z
M\4!0%@IN0G .4*U0++0(Z<&K'$R3$6HQ>@KKI4<MVZ^C GAH% 4A7NJ*)(%+
MJAND+:B% IQED-VP5J7(?C;BZ=^3>)2#/LQ\A.,4(]\BIMHU(II52$G9#)]K
MYS5V+#P*ZIP)V :X^^?3!-:!L29T#4,?V)RB1@/I8F\#\?O7+):))Y7#&5Z)
M55_*45*$?D;W\2P=A13M_XYG(K X$% 6$]Q@T0!!?.92>IAIO8E")8T/8@'@
ME%=BKAG'W*A[;.K%+;Q/FYF_Y9;^'?7G*"YZ&H9BIQ\+_FV'#\ D.>#^A$^3
MZNL?M&UHJ4_^HWF 4)](>#*/*_06+R:5.Q";BG(26R5*V*Q$4'<7I$].CH;Q
MSR9)79"D:Q*EB[5R\;-"GA\&6'(,G@N0-:R,1(TB%FH@\64U+=;%9&E RP2A
M>QH/>2#_SC>A\Z02(-@.QV.9J,3.IUC".B)?)+1.5=B,0CM?35);+A@K4<67
M*JBX E7,WW9X&Z$T2@]_AD[0#8$<&[P!(%A<X9]QF$4E.BZM$ZGP1/5!44].
ME45R3R&>\-C;\</P&_&&V;&C%/5TF4!;GD/84.CZ*70VU&@!Q:X34FLL/WKQ
M3OZ@^EX+MXX29J(HT B<6X06BIGTQC7OO=IU&X^XYE&:1A0$^>V7E_OJC\ED
M4G/'8HC+KH$=L$Z0+I#+"?A5[H)LPD8@_^C^$G1P1^PHYA,,^,C0AH9<2D,D
MRK9%,R O_%(Q>E> B>NQ\S#E0U\._/!OL'6/CUJLA<GD*^ZK($1$VT$C&"QV
MLJ+!NCB"N\=]>%1#]6A3!8I0W2@Z'29X[$LLTP;VQPD,^2V[^IZ\>DS-8I@/
M;W*3\8!_'XD!S_QT-F$R@OU<825,[C_.8T*73F!9A=Z$P!S+XEW,O;&:;L'5
MRL0X<K#;&F.MO&)K=B1 9S#0-1I'X/"4RG6*<IX<*;G>-D5!Z$8L1<V=W(3;
MF'>_>1^YL/?R]B?3^(?G*Q7(1.M0E8<=XB#/JTEKZ[)UE4RSUMSBVUM7VQ:T
MEJ_*;'?EB VS/2BSW2A\;> _E<:KS#:Y=R7NRC+;WJ#@KG4E>A=+:^RH/'[U
M"CXLW34E?&@R8+L:M4FHHDP94Q8D%A0A3$/XG7O?4:+[$(2 $N;Y"H^BML0&
M02'GT_;4-DGV!%)<;IEC<#L;JQH:"IYC"P_8W%M]E2 )&&=3L,05N6(A^ B4
M+5JRB;Q.IVQK]U5]FWE\FFPSK#_W38G D ;TT7V80Z=5JO)V7+1Z!JP0EN!2
MO]+K6KWQJVJ.Q;0I/B*!A6G;_X:J).4L^!S[.7$:(#BV(+"GAK]4N9ZJBYHK
M)!))Z1I@+951HJ(C PC*NW#7C3.PO\G/J-<:]5^-VP&?M[K;%(U'SYK6U5),
M#5_1Q_<:XM@"JEHN E@EIKK*D$@*4.S7WM0-*+JS#V]7'WY4>7CI$75X!/@6
MO3!%2@#IH7PK';@5PQ ^.01;V'<0JFH/[>G@105!5]]/;^\#P!'. -9@5=0Z
MA:>611IK,^[:#45K\[V#;,RGU'U!G1(#KH9SY05MIB!3DZ,:H\AX/[S2*;,<
MPT3[)%>-?2M5;D[UU]#7A8 F84O5:0I,^8K5=+!*45OU%4J.%[_>MB2B6?@(
M/J1JKL)6'42DJ@HL)57+=PVPCUEU4X+SY^>[$V3-S/" Q!28 I PU@XQD$E<
MWG4W"LDZQC12$!P7A-4'DWU<>A<&[/9(6=7K+*J-:ZP#?"SB0*=/ UUMA(99
MA;DIB[Z@8X5C+BY5S8!YM,)L)E\-^MRP1$^@9I:!3L6"/T']4\A;PM>JFI
ME(8D/^:>P)3BW&OSXD/=3$DR@X9"8@]E0AL%L/2EXD'>3Q3$ CE > I8IT)9
M^46 L]D7Y2Y^$OJ"!DJB!1 &.=V'64IM0OAXZH5$3*A^(FKW?)2"QS5:@"^?
ME 58LNT\(+!\_&C%+"14XI58!R'\A,3,E"B#1Y$@?E]@.!(3F4+7D^[[TS-V
M5N+.4M&KL_RJ\PCMR/PZ7$KEVEFA;,IHE[NWWV-J:O)Z65]C9'C/.@*;B6^0
M!;)J,]"L)X'MW-J/F"[S(GZVFCQ-T IP^K_S%5I@"<9E2Z Z;)&:))UBS(>R
M\\+4# $!]9+%Q@!3D892A-G!5X_Y-_5NW4]=[K2F7EUX";QE2-IW'&8 NRS"
MJX[E /#W$90.$L81*@U8T=;_[=4=@"7^#];@MF[.IC5H=T M/M<J9?N2JDY2
MTS=<]/]NYC&L$O(# &^1R5%"I^G&!7N#C!<R46/5HH=#S'T]4<$"9[9$"!9X
ML\[<:!T$E"63'$J@LF(6%YJVFKPB/E5R"KR[,FMK(S,F@Z#^YK"OA(Q7FZFV
M>-R(H@W:_97UVOUJH]SOI=ROMM>DVN>SQ]^GVR\FL)[ISC'ZD)N*][G7VECQ
M/F^(-??N88@=;0RQC2%6$((%QH7]AMC1TS#$CFPTQ-9GANU;9X;AH^<*2<HV
MEZ=GJRP>L_4<3*S<PKJWC459H+GJM4F,!S,%P!7_S3 X3@U2F(&J9"M:8U""
MIE]&U<:533:*EBJS+4^8S\3,;S3H'LIB>R!3H+,Q!3:F@%6E@/:; AUK3 %5
M<ES47[1TRKY2'% *T#@5(\$D^K4,D,F3(EA+R-5,%WZVW30EPDLJE)=42"^I
MT%Z2#V4N<Q0*S6<+QV6\9[,DM$4.WN@2=6QTB=89FWYMG5-4.$1[6X--7/H^
M3M.@<)HL-=D_!S1-]EBLM8ZU!KIJ@-X;R D:%0=T,\A\'UV=RAF_>&:J\OD<
MXY4I7RRO12U?[F#;UI(>+W$= 4DJE5?I<T/'T(,+5=4-K4*_PS1ME:PUY6'0
MTBU1 78@-%<!QB![/H+\C;6"?+?6W/(V@OP^@MPK!+FIG[U.$6PD+80/AF"L
MCA["WV;;.+T,K$1Q+=Q,'64AAQ*'P-#0%_CB$TV.3W!<32],M4RZY'&,,^1)
MS@49=ITZ&/\9FT@;O9Z[KHA2$IG5@))RV%&,\BLUPJ/T8S4,A7@MA9H^J3)N
M/H2%+VPJT*?,=1  5#]KZF1)%IHWD.$W#XQJ/ZX>H63V"M279 C&)3>3/ <8
M<]]W\@ICU!'50FGJ)0 JUN!2UOGL.TPPUR1]\Y[<V5?2F0GF77@S01LCE.<C
MCAH$[IN+:F+?,*XK#=UOA6[:NMZF$8SF@"B,&P[P38NZ AJU_;U?<VX=9(HG
M<TV4%^B;B,+6U'1=Y!T;Y5=@L3!P0O4=]=KKU5YB(A54TO_W(^S"]#5@Y3JG
MLY\39!RIR$3/==(XQ+%(KJ@<>9,J1VT[;Q%_=OY#HVZ/WMFMZIU7M48=>WPV
MBN?NBJ>_;;D#\5$&<IR!A.#):+TN!&/'J@6BK$#,B:='O)@K4Q$X((BD7SJ6
MS!U)D&F@,V(N?;RSXG\DE0$+O4]G),12Y@OL1ZM<JER#R-0$V>$=E+%ES]R1
M[=*Y<$K5CKFDHW+86"\X"U B@-Q'F0#*8>30GZA;Y17WA3EM)QF%<;JC3[D
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M0BYVJY\K3/[JU:OH^CZ-%:_V7D;7+VR6'K_C>5_PUR@=^^_^'U!+ P04
M" "=@MQ6S>-&:]L3  !H@0  $0   &QX<G@M,C R,S V,C,N:'1M[3UI<^+(
MDM_G5]0R/?/L"00ZN'V\<&,\ZVVW[3#NG8[=V)@H2074M)"8DF3#^_6;624)
MQ&%CMS'8K_VA&U =F5EY5U;I\)_CH4?NF AYX!\5C))>(/\\/OP/3?OZ\>:"
MG 9./&1^1-J"T8BYY)Y' Q(-&/DC$-_X'277'HUZ@1AJFNS5#D83P?N#B)BZ
M::6MDH>B19NTVJA02ZL;MJU5J,ZTAFD;FLYJ>HU5'=JP6+'?JC3<1JW9=#6K
M;EI:Q3%JFFVXNL;JC1ZKFJZN-QM%M]6H5!VKYQK,HLV*7G6;/=JHNV;-=.Q>
MKZG;..T@ OP 1S\\*@RB:-0JE^_O[TOW5BD0_;+1;#;+8VQ34(U:8UMX/-<4
M?Y&-35VWRMP/(^H[+&W/Q]'RUMSWN,^0BN5(4#]$(M$(J SCF+JFFYIA9I.&
M?!ET,*%1_OKYHNL,V)!JBU.O@M.P9J9/F\/W;P\@AH]M&LXBIH7,R?6 [Z5^
M</<@;D95TQN:9:3CN&R*FYPQ'00>("FF1%@ ,+=(^%0V;7G4[Q\5F*]]Z19@
M@1EUCP^'+*($NVKL[YC?'17:@1\!XVJWDQ&@Y*AO1X6(C:.R7._R\4\__708
M\<ACQ]Y8C#5D6+UF6H=E]>-A60UM!^[D^-#E=R2,)AX[*K@\''ETTO(#GP$
M?-S"ADRHC]QUF2\_PO-+D![!'37_.+IAO:,"[^FLV6"LJM==N^)8U8;9;#0:
MM4JM7J]:==WY\Q3)HM=U0Y,?FA8(I4^'.#7CK8X/\$W:@(Z@WKGOLO$G-BD0
M[AX5>III%(YU8!M I&&:A^4<&)N$Z@34A(NJXLRC_0)1' '#CJ-6CX^9J_6H
MA\R5@&D6CL].+KJ=!0C+>1H*UF." =.'2Y8>6:(52N$ '(ADD58$"WY4"/EP
MY"$OR]\& E',K7)I'+HP1#D_AII_.FD"0QC$0GZ3VJ&5T$WB\BRZI0,QN93I
M-^[B]QYG@DB V%+9:Y]_RB_Q?.?C]*?\Z".@;^"FWT"3B.@45/HQ J7I=4TW
MTG[39QF8[DS3IF;ITRG4D_1[.DDY1ZB4JAD9RS,R4P;)4N(ER?F83O_3*,SV
M241RR'UMP-#NM"IFJ5X=10?WW(T&+4/7?RG(IL>'X8@"4]FB# .HSVJ<A=%0
M[VD MZ!.U KCX9"*"0P24=MC:1L[$ "^Y@2>1T<A:Z4?#E+MH'2D)CL=P A]
M -$.HB@8MA \,+D1=ZBG48_W_1:2*7D\A;RD*^@C(%/DIC,GCTOR43ER%Y\U
M&Z6FOOJQ7C*R9V4YMD@;)#0$  NR'V"%E#HJ6(4YQ!-4S%%$PL#C+OE9EW\'
M(^JZW.^W=&+(4:;3E"4M9NB]>DEF%D-21A') 8YFHJ"ZI<\!Q$"TTME[P'&@
M:H;<F[3^<<N'H#<NV3VY"8;4_T<Q!%L%BRMX3S4,^;]8RP <U-=[A7T=QI%K
MEU##,)&67R[/;SNGI'M[<MOI[CRTW4[[R\WY[7FG2TXN3TGG:_L_3RY_[Y#V
MU>?/Y]WN^=7E%E$PUD+A#QH.@)&BP"^2TU*[!!YEM=+<(<I7EH+]Y\+?.B#_
M%8>@O2>%W1 )4U]KA<ZN;CZ3#?H4:?2A?#CE.8#Z;VB?%MV&'URQ>51K:W$%
M*)Z;SN4MN>E<7]W<[M#*+ ?W.A9A3"'$C0+290Y&,<2P2""(4=US]TG0D_$N
M/(H%CSA,W!D[ _!#&3EQ(GQL-*W* IH[LF3KT0!].,3DAHT"$9&]]#NCX,6Q
M,"+L#I, 0CYF[G[K-:3^6OJ2'>5AYB,*%W[1AC#G +MI+IUH$X!58WX68!2.
M_ROV&3&MHLQ$/$=A[);TK:F3-QYXWK ^#S'JCR[A24IOJW!\P<8<IB/7 PHK
MY;!8^K=AD9S[3FF'%/9Z=-SKC,'[E]BC)(@,:T)#$HZ8@[&62[A/>!024 @@
M&&+_26B];CS1M$IFO?*<<,+"B*JZ5CCQI&$AOFFN[OKL8:U2HUIY2O"S*M))
M(QES-,98YF!A#1>('HQ>7X'KKR+U(,.! .TOLWS="/1O.XC]2$S:@9M7SA@\
M8PHA8B,1W.$X4ZU< 5/#/'I/!5NI$))%^[$>#Z['&?<8C&Z#(DEH6Y59(<W2
M#</X0=SO(NXM'9\GZ31',GR>TK7"<;VFZ95ZQ:@U'R3U6U PCYI#2?,]*?/H
M%0?@#0OR%SC#H<N5NQSTI&_$9W6$;"KZU.?_DM_WWPH/KDF/=C <\A!WS0C*
M(E$L\MZP/"_=E+HETAF.O&#"A%SFO&@L17QYNN\Q%V_;'O::P=+&U<^)ZPH6
MALE_%P" D:J>>N'8K%2JY)8Y Q_P[4_(62 P0OOHW;FE(C&,:$#.O" 0.^1Q
M[Q9=V_#Q2MP&]YE;TB@<W\HM[<#UJ.^&\Z0K;C+<S<$FM>R5N ;/B<N=WC4=
MJR9@P,9T ?)7 _PZ ,B\_^$CY0\FN3H=+&7=:JSV1W8V^DO0PM!O)& I^(AZ
MA(V9 U'M'4:$H/]@.N 6 D@3Q/IIP=\;4GA[&V0B%,83P6B.;0S0<HM,L[])
M9KX(P-Y>#P)_SJLVS,)QHV:!6ZWK;X^+I[F:7W]NF$;]("01\]@(\22^1+1(
M@+N]&#T2 F$9!:JNR<I)>DSY+]Q'KZ!EU>2>WW.8>]4XFR/:\DS]3*)7)7V8
M8"X9+<L2FWMVEA\^<:)6BNRK)W8JIO&LQ$X%>JZ7*GG*L*91:NHO/VQ%+UEU
M<RN)'47O+3GAMUB-I++QSH X'@W#3409V\514*F!NI.A'7A[X4;BJ*UB>)DD
MDN4BLG0'";3(_8##+U-5L]$$PBN18$&S;CIODRCMB6':4EPR\VT5CC%2!SIW
MH\#Y5B0C*L@=]6)&/F!]S:NDRMXKU1.I54*;D;Q2.+[X>O/U!V&_GYW3G6:U
MTS8?"Z(6R8>!1E5%LI<T=.G?Y'<OL"%LZ8++YT3D,Q7?6/1XOG)EWB;OF]3R
M"[3,&S0:6_/BV@/F?)..&1U!N PQ'*8O[6!,;.8%]X0KK^T,2$H:VB?2XQ[:
M'QZ".QPQ -]%3R_DP]B+J,^"./0F)*01#WL3V3/I$-B O4R$A:DG.+-5&,-
M H+$2?JL!\Y?<(\=,8;GF#X,6RM]Y#S!+4 \D1#-8STP-&:Z! F]M:>YS7_
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MA*8L^ 8(>X'0+\C,5NDJ_:"K,3A'+CF3O@\C%Q=MC#QVF) *X)T@H,U[L<!
M'/Q$9$ E[NA^@@^;Q-]J#_Q#O4H $@]=Q7N*OB3XG&KGA=Y1[DGO#+U45]![
M0J-4V62U3<%(^;/@S@H4"*F;+%WI)O QOV3!/BB@8;9A,R?.1?*AJF> "#:D
MW ]? H*99$.>""BO'\P9Y.%_8K.GS6FSZ)XQ'ZR/P["PBQARW.RK9>2@H-*Q
M[P6QP N=%"! (MP]3.D^][287ZP9>/G3R%-$<_ 7;DD"A12G9BV@=2C7 'IC
M]!$!3T[)J2*8$4^/&*CUX]*>A)$6^, J(SJ1VDY%-44$S@\ &HA<>C.HOD^#
MW)T2%A<_'@&5>K!L<JLRW8+,+VIJL273]67\F*@["E(H1!+#03P'\1I$D>&
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MOS.?"8@C\8U.(?-6I4/7>9_'<U^9MU:_-W:TOZQ>'"_?-G_\_U!+ P04
M" "=@MQ6FGA52&P"  !G!P  $0   &QX<G@M,C R,S V,C,N>'-DS55;;YLP
M%'[/K_!XGKFF*: DE9:JTJ3LHJ[5^C89. 2KQF:V:>B_+W9"D[3-NDA[&"^8
M<[[OW(^97G0U0P\@%15\Y@2N[R#@N2@H7\V<VYLK'#L7\]%H^@'CNT_72W0I
M\K8&KM%" M%0H#75%=(5H)]"WM,'@KXSHDLA:XSGEK80S:.DJTJCT ^C 39H
M94H2<A:/283/@RS#8^(#CL,LP#Y,_ F<Y22.X.,J'<=%/$F2 D?G883'>3#!
M65#X&,[C$L["PO>3V!KM5*KR"FJ"^M2X2CLU<RJMF]3SUNNUNXY<(5=>Z/N!
M=_=E^<-"G2V647Y_@.XRR09\Y!EU1A0\PSO9/<,9=$U%9$W<7-2>R=6?A)&#
MB-:29JV&J[XHEU"2ENF9T_+?+6&TI%#T%6=@:GH V%-K(E>@OY(:5$-R>,_C
M?(20J0*M&R$UXJ]X>V4(DB3Q.I.7@S956XJ<:#L,1\M@\=@<<1#B*' [53C>
M7[D]-$2YTH3G<(KO_@L/O'\1PZZGI\4P\$Z/P1I3D+LK\> 50$WGPK?=JV-P
M<\#F<.B3<"ZTY1O)5M8TE)=B(^A%)O!TB/X:RF%-7LW^&R-B7RF1N13LG7GR
M&BD:D)J"VM\;:Z"24,X<LSUXF-I?C&1N'\D >>7@L 5&[?448,M=)@-7/S8]
M5_4-8+"IS?^<>"/AU,1[BNKO"]OH$_,W_)M>CV@Q<Q:BO_D=9&2WUY^/W"O6
MXP8YF!J,%5!23NVX^?8)$-[](3"RK*GW$OO"2JN@^,;G]OPRLRUY"_D#,2<L
M;]GIO%U81VE;X5"Y[69YAZNU^=Y;/RO8[/1\] 102P,$%     @ G8+<5MK>
MM Y'"@  &ET  !4   !L>')X+3(P,C,P-C(S7VQA8BYX;6S57&MOVS@6_=Y?
MH?5^V07*FB+U8M%FT,VTBV(S;="DF,$N%@:?B3"V%,A*D_S[I60[L6+*%JE8
MU7Y)%/GJ\MQCGLLK/O+NE_O%W/LABV6:9^\G_ALX\63&<Y%F5^\GWR\_@63R
MR\FK5^_^ L ?__AVYOV:\]N%S$KOM)"TE,*[2\MKK[R6WN]Y\6?Z@WKG<UJJ
MO%@ <%(_=IK?/!3IU77I(8CPQFSS:?&6$AHF <4@]AD# 842)(CY ,H(1C+D
M-,'R]=7;(!%)1(@ .$88!-R/ /,%!#).E R1@) DM=-YFOWYMOK!Z%)Z.KQL
M6?_Y?G)=EC=OI].[N[LW]ZR8O\F+JRF"$$\WUI.U^?V._1VNK7U"R+3^]-%T
MF9H,M5M_^L=O9Q?\6BXH2+-E23->-;!,WR[KFV<YIV7-^D%<7JM%]1?8F('J
M%O 1P/Z;^Z68G+SRO!4=13Z7WZ3RJM_?OWUN;9),*XMI)J^J[_9<%FDN+DI:
ME&>4R;E&7WLK'V[D^\DR7=S,Y>;>=2&5V>V\*!I>*Y2D0NE'%<J_MC4V[0'_
MA?"6NUA? %P=[I>7PKB/TR\O!O=29PAY?,!;S?2&O.I0'S,Q5-]];*HW].,C
M?JEND9=T/D"W>&IF"_*\NG&FK];-5([V)-.ZG77JWH(J[TN9";G*E@W77BK>
M3_353,AT]C$KT_+A5(]\!9U_U@_<_TL^S&@BL*\4 2(AOAZ[ @0H9APH287D
M :,\X;/RL5//9 :^7VS:KQLYT,+$(K:R1:.%7.:W!7\:W19STY"E1ZMJ?$NF
M&5W(Y0U=/Z!A5J7 "OG)"J2W1NG5,#V-\]WT*207(N?'IV<^,F9RWL RK\J!
MO'@>?<X/1_^DKZ4&7H>^E/S-5?YCJI_5%"!478#JHI95N\?ISI?WH=C@I 4_
MP//:8LIS7>O<E*!!N2KR1<> RKSC][ZB3C<[\?)"R$)7L(80#/WODMY_%MIG
MJM)5%?;E=L%D,?/]Q&=<88 D(R# L=*"%@P(2'#"8R@P"NP$W=+22(6MT7I-
MN-X*KZW VPCN*O07H&T8P=LSYB#\ VST2 !MG@=.! <"W$T(AQYP30P?A-"=
M9+G^I:L+Z<^()$SI$@'0(.(@( $#"6,81#XC"$<A2G!HEQ0,K8PT(:PAOMY<
M>!58[VLF;1."B=BNR: G7<,D GNF'!+!'B9Z) &3UX$3P)[ =L6_S]A>^)<%
MK::[+AX6+)_/.!68AC  ,,(1"& < U;5]8S&41A 3&1 NXJ]X7EL E^#\U;H
MNLNY2==A"3N3<&39=HS?2J3&6)V$V?0TF!B- 6P+T&S@.MI^2N=R71AJI5$?
M1A& DN-*=P(D6'#@TP@%/%"*A['=(/OD?&S26X\8%4#'\GJ+N*Z#J!L=PXR=
M79AP&"UW0^XQ2&XY&WALW UC=T@TV-B+\KR0I_EB(36N:HWG\W)Y*XO+:GJL
M^*I4)5(4490$"8"P6H012@^.,!& 0)G  *% 19U?CP\U-C;1:KR ;P'V5HB]
M%62OQMQ=Q@>I/BSKER3PR#+OQ9V5\+N2XI0(#CH?+#%T#7,[471^QCYQ7.3S
ME*>E+@Q^HUJ+*9W/?($"D?@A$+)*%00K0"C4[]"Q'N3#4#&9=![/=]V/+3D\
M(?0V$+OG @-[A]7?CY,CZ]V&#BMYMT?M)&B#N\$DW![*MFCW6/6<XCK5EU^+
MR_PNFP5:HR)&")#ZG9<E$##... ^XM3'A&+D-L'UU,;8!/M\TJ9"JGGT*JR.
M4UM;A%I.;+G1-/"T5B>&W*>T=CGH/Z&UY?/G3&?M!M4ZF64P=17XYXSGQ4U>
MU//B%Z7.&Z?Y;586#Z>YD#.*J8SC*  \#'T0\)B!!,$82(9\+G1UK\+(3NQ[
MVQNI\!N87WLUZJIWKY%[%73;/+"?]ZXYX<78'"8_]"+2(5UTHJ='ZMCO?^ T
MTBG8W932[3'[]%)M69R?7^?99NZ)*80113[ $NK"04D%& X9B"(?8J'K?11T
MWO_RW/G8$D>-SZL!6D_:[1!W.!GTH>/(RK=@PDK@;2$[J7G'V6#2;0MC6Z>M
M-CV+^O-\6=+YO].;>L@)61QB3@@0+) @"!4&":$)8$S!(, T\;612UW?:&9L
M0GU>N*[ >AJMTZAN9-:RP'?F:^ :ORM5[F6^D8G^E7[3[<\I]HVAM=;[9FM[
M^?]>I&4ILVIF[S9;[X59SF+&$&01 DSH,3D@D !**0$!%-(G88ST:WU7Y1M;
M&)OHUR"])LKN6C?3>%CFO<DYLL(M>;$2]M[8G31M]CB8G/<&M*WD_8;V(JY>
M_C\4DJY>T/T0*\%#$(8)!P'"$M!0E]>2JE@@"I5(6%?M;CL>FV3K":4*G.6P
MW"#KL$)=*3BR,#M&;R5(4ZA..FPX&DQ^)OC;JC-^[B"V_(<L/K!E65!>=NE
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M,#(S,#8R,U]L86(N>&UL4$L! A0#%     @ G8+<5MH -FVM!@  V#   !4
M             ( !4S\  &QX<G@M,C R,S V,C-?<')E+GAM;%!+!08
..!0 % % !   S1@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
